Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dolocare Forte
- Development stage
- Unknown
- Lead developer
- Procare Health Iberia
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Dolocare Forte is a marketed nutraceutical developed by Procare Health, designed to support the health of joints, muscles, and tendons. It is formulated as a combination of three primary active ingredients: curcumin-standardized turmeric (*Curcuma longa L.*), *Boswellia serrata* extract, and Vitamin D3, often including piperine to enhance the bioavailability of the curcuminoids. The product leverages the synergistic anti-inflammatory and analgesic properties of these natural components to manage both acute and chronic musculoskeletal pain. Clinical evidence indicates its efficacy in reducing pain and movement limitations in conditions such as osteoarthritis, tendinopathies, and fibromyalgia. It is positioned as a non-pharmacological alternative to traditional oral analgesics and non-steroidal anti-inflammatory drugs (NSAIDs).
- Brand names
- Dolocare ForteDolocare® Forte
- Other names
- Dolocare Forte
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)VDR (Vitamin D receptor)ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on Dolocare Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dolocare Forte.